Drug Checking
Helping people understand what their drugs contain may help them make decisions that reduce the risk of harm. Drugs from the unregulated supply often contain unexpected added substances and unpredictable dosages that can result in different effects than an individual may expect, including overdose. Get to know the facts about drug checking.
Heading
Drug Checking
Explains what drug checking is, what it does and how it helps people. Also addresses how drug checking benefits communities and explores public concerns about it. This brief is part of a series we created to help people and communities understand complex responses to support substance use health.
Heading
Drug Checking Poster
Summarizes our Drug Checking Evidence Brief, which explains what drug checking is and how it helps people. Also addresses how drug checking benefits communities and explores public concerns about it. This poster is part of a series we created to help people and communities understand complex responses to support substance use health.
Opioid Agonist Therapy
Opioid agonist therapy (O.A.T.) is a way to support people in achieving their health and well-being goals with the help of medication. For some, the goal may be to stop using opioids completely. For others, it may be to reduce their use. Get to know the facts about O.A.T.
Heading
Opioid Agonist Therapy
Explains what opioid agonist therapy (OAT) is, what it does and how it helps people. Also addresses how OAT benefits communities and explores public concerns about it. This brief is part of a series we created to help people and communities understand complex responses to support substance use health.
Heading
Opioid Agonist Therapy Poster
Summarizes our Opioid Agonist Therapy (OAT) Evidence Brief, which explains what OAT is and how it helps people. Also addresses how OAT benefits communities and explores public concerns about it. This poster is part of a series we created to help people and communities understand complex responses to support substance use health.
Supervised Consumption Sites
Supervised consumption sites (SCSs) provide a supportive and connected environment for people who use substances. Between January 2016 and March 2024, more than 47,000 people in Canada died because of the unregulated drug supply. Evidence-based supports – like SCSs – that consider the needs of different groups and communities can help reduce harms and save lives. Get to know the facts about SCSs.
Heading
Supervised Consumption Sites
Explains what supervised consumption sites (SCSs) are, what they do and how they help people. Also addresses how SCSs benefit communities and explores public concerns about them. This brief is part of a series we created to help people and communities understand complex responses to support substance use health.
Heading
Supervised Consumption Sites Poster
Summarizes our Supervised Consumption Sites (SCSs) Evidence Brief, which explains what SCSs are and how they help people. Also addresses how SCSs benefit communities and explores public concerns about them. This poster is part of a series we created to help people and communities understand complex responses to support substance use health.
Involuntary Treatment
Heading
Involuntary Treatment for Severe Substance Use Disorders
Explains what involuntary treatment is and examines its effectiveness by focusing on the evidence, legislation and diverse perspectives about it. The brief also provides a thorough overview of the issues involuntary treatment poses for decision makers, healthcare professionals, and policy and program developers by outlining how substance use health, treatment, human rights and public safety intersect.
